Michael Sarcone
Stock Analyst at Jefferies
(n/a)
# 5,042
Out of 5,090 analysts
9
Total ratings
n/a
Success rate
-30.28%
Average return
Main Sectors:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Buy | $29 → $36 | $33.32 | +8.04% | 2 | Dec 4, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Hold | $160 → $85 | $136.81 | -37.87% | 1 | Oct 24, 2025 | |
| ALGN Align Technology | Downgrades: Hold | $215 → $140 | $157.21 | -10.95% | 1 | Oct 10, 2025 | |
| EDAP EDAP TMS | Downgrades: Hold | $8 → $2 | $2.40 | -16.67% | 2 | Apr 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $35.86 | +164.92% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $108.51 | +15.20% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $6.60 | +51.52% | 1 | Mar 21, 2023 |
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $29 → $36
Current: $33.32
Upside: +8.04%
Inspire Medical Systems
Oct 24, 2025
Downgrades: Hold
Price Target: $160 → $85
Current: $136.81
Upside: -37.87%
Align Technology
Oct 10, 2025
Downgrades: Hold
Price Target: $215 → $140
Current: $157.21
Upside: -10.95%
EDAP TMS
Apr 4, 2025
Downgrades: Hold
Price Target: $8 → $2
Current: $2.40
Upside: -16.67%
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $35.86
Upside: +164.92%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $108.51
Upside: +15.20%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $6.60
Upside: +51.52%